Those events also happened in patients reporting full isolation.

They're also caused by Covid infection. Which makes sense, if the spike proteins produced by the vaccine cause these issues, then so do the spike proteins produced by the virus.

That logic is most likely simple, elegant and wrong.

Welp, I'm open to clarification.

Given both the vaccine and the virus can cause myocarditis or pericarditis, and given that the only thing they have in common is the spike protein, I'm curious as to where you think I went wrong.

Where you went wrong is getting it backwards. The vaccines are orders of magnitude less likely to cause cardiac problems than the virus itself, for fairly obvious medical reasons.

And that cardiac events in both cases are a minor part of the greater effects and dangers of catching the disease.

So it's about not focusing on the wrong things

> The vaccines are orders of magnitude less likely to cause cardiac problems than the virus itself, for fairly obvious medical reasons.

Do you have a citation or evidence for that statement? Estimates for cardiac vaccine injury are in the 4-5% range. Your statement would imply that 40% of people infected with Covid would have cardiac issues. The evidence in low vaccine rate countries (or Africa) contradict your statement (no where near 40% of the population is getting cardiac issues).

The vaccine induced thrombotic thrombocytopenia caused by the adenovirus vaccines turns out to be due to PF4 binding to the adenovirus capsid and has exactly nothing to do with the spike protein, even though that is the only common factor between the vaccines and the virus. But it turns out that the clotting problems are totally separate.

So that is a failure of the same kind of logic that you're trying to employ. You have a virus with a clotting issue and a vaccine with a clotting issue, and they both only share the spike protein, and we know for certain now that isn't the mechanism.

A quick search finds literally dozens of articles in medical journals like these:

Thrombotic complications are frequent in COVID-19 and contribute significantly to mortality and morbidity

https://pubmed.ncbi.nlm.nih.gov/32857878/

One of the special characteristics of this disease is that it may predispose patients to thrombotic disease both in the venous and arterial circulation.

https://pubmed.ncbi.nlm.nih.gov/33719953/

Which doesn't tie the problem to the spike protein or relate it to the vaccines.

Oh, it wasn't clear that that is what you meant. Thanks for elaborating in a sibling comment.